UFUK AVCIOGLU

Dr. UFUK AVCIOGLU

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2022 in Hepatology Forum
Verified
Journal Article
Open access
PDF file
FGFatih Güzelbulut
Fatih Güzelbulut
UKUmit Karaogullarindan
Umit Karaogullarindan
HAHikmet Akkiz
Hikmet Akkiz
EAEngin Altintas
Engin Altintas
CDCoskun Ozer Demirtas
Coskun Ozer Demirtas
RIRamazan Idilman
Ramazan Idilman
Background and Aim: The aim of the present study was to examine the etiology of hepatocellular carcinoma (HCC) by underlying cause and determine the characteristics and clinical features of patients with HCC. Materials and Methods: The study comprised 1802 HCC patients diagnosed and followed up by Liver Diseases Outpatient Clinics in 14 tertiary centers in Turkey between 2001 and 2020. Results: The mean age was 62.3±10.7 years, and 78% of them were males. Of the patients, 82% had cirrhosis. Hepatitis B virus (HBV) infection was the most common etiology (54%), followed by hepatitis C virus (HCV) infection (19%) and nonalcoholic fatty liver disease (NAFLD) (10%). Of the patients, 56% had a single lesion. Macrovascular invasion and extrahepatic spread were present in 15% and 12% of the patients, respectively. The median serum alpha-fetoprotein level was 25.4 ng/mL. In total, 39% of the patients fulfilled the Milan Criteria. When we compared the characteristics of patients diagnosed before and after January 2016, the proportion of NAFLD-related HCC cases increased after 2016, from 6.6% to 13.4%. Conclusion: Chronic HBV and HCV infections remain the main causes of HCC in Turkey. The importance of NAFLD as a cause of HCC is increasing.

15 October 2024 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
EÜEnver Üçbilek
Enver Üçbilek
AYAbdullah Emre Yıldırım
Abdullah Emre Yıldırım
ZEZeynep Ellik
Zeynep Ellik
ITİlKer Turan
İlKer Turan
BHBüşra Haktanıyan
Büşra Haktanıyan
RIRamazan Idilman
Ramazan Idilman
Background/Aims: The aim of our study was to investigate the underlying causes behind the etiology of cirrhosis in Türkiye. Materials and Methods: The study was comprised of patients with cirrhosis located in the gastroenterology clinics of 28 centers in Türkiye between January 2000 and June 2021. Results: The study group consisted of 4953 cirrhotic patients (median age: 62.2 years, male / female: 58% / 42%). Among the patients, 39% of the patients were compensated, and 61% were decompensated. Furthermore, 47.5% had Child-Pugh class A, 38% had ChildPugh class B, and 14.5% had Child-Pugh class C. The most frequent complaints were abdominal bloating (28%). Ascites (54.2%) was the most common manifestation of decompensation. The median Child-Pugh and MELD-Na scores were 7.0 and 10.0, respectively. The most common cause of cirrhosis was chronic viral hepatitis (43%), followed by cryptogenic cirrhosis (CC) (19%), metabolic dysfunction-associated steatotic liver disease (MASLD)-related cirrhosis (13%), and alcohol-related cirrhosis (11%). Among the 950 patients with CC, 416 had metabolic abnormalities. If these 416 CC patients with metabolic abnormalities were categorized as having MASLDrelated cirrhosis, the proportion of MASLD-related cirrhosis increased to 21%. Thirteen percent of the patients were diagnosed with HCC, while 4% had extrahepatic malignancy. Female breast cancer (18%) and colorectal cancer (18%) were the most frequent extrahepatic malignancies. Conclusion: Viral hepatitis remains the main cause of cirrhosis in Türkiye. However, its prevalence seems to be declining, whereas the prevalence of steatotic liver disease-related cirrhosis is increasing. Cite this article as: Üçbilek E, Yıldırım AE, Ellik Z, et al. Changing trends in the etiology of cirrhosis in Türkiye: A multicenter nationwide study. Turk J Gastroenterol. 2024;35(10):772-777.

7 October 2022 in Medicine
Verified
Journal Article
Open access
UAUFUK AVCIOGLU
UFUK AVCIOGLU
HEHasan Eruzun
Hasan Eruzun
MUMuge Ustaoglu
Muge Ustaoglu
The gamma-glutamyl transferase to platelet ratio (GPR) has been reported to be as effective as the aspartate transaminase to platelet ratio index (APRI) and fibrosis index based on the 4 factors (FIB-4) in showing the fibrosis stage in patients with chronic hepatitis B. It has been demonstrated that APRI and FIB-4 are successful in the assessment of fibrosis in primary biliary cholangitis (PBC). We investigated the effectiveness of GPR in predicting advanced fibrosis and cirrhosis in patients with biopsy-proven untreated PBC. A total of 35 patients with biopsy-proven PBC were included in this study. The biopsy fibrosis stages of all patients at diagnosis were compared using the APRI, FIB-4, and GPR values. The diagnostic accuracy of GPR for detecting advanced fibrosis and cirrhosis was also investigated. The area under the receiver operating characteristic curve (AUROC) of GPR was 0.84, the cutoff point was 4.81, the sensitivity was 0.41, and the specificity was 0.96 for detecting advanced fibrosis. Our study showed that GPR was more sensitive than APRI and FIB-4 in detecting advanced fibrosis in patients with PBC. GPR could be used as an effective noninvasive marker in PBC to show advanced fibrosis at the time of diagnosis.

1 January 2023 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
UAUFUK AVCIOGLU
UFUK AVCIOGLU
HEHasan Eruzun
Hasan Eruzun
Objective: Acute pancreatitis can cause local or systemic complications and has high morbidity and mortality rates. In the early stages of pancreatitis, a decrease in the barrier function of the intestines and an increase in bacterial translocation are observed. Zonulin is a marker used to evaluate the integrity of the intestinal mucosal barrier. We aimed to investigate whether measuring serum zonulin levels would contribute to the early prediction of complications and severity in acute pancreatitis. Materials and Methods: Our study was an observational, prospective study and included 58 patients with acute pancreatitis and 21 healthy controls. Causes of pancreatitis and serum zonulin levels of the patients at the time they were diagnosed with pancreatitis were recorded. The patients were evaluated in terms of pancreatitis severity, organ dysfunction, complications, sepsis, morbidity, length of hospital stay, and mortality Results: Zonulin levels were higher in the control group and lowest in the severe pancreatitis group. No significant difference was observed in zonulin levels according to disease severity. There was no significant difference between zonulin levels in patients who developed organ dysfunction or sepsis. In patients with acute pancreatitis complications, zonulin levels were found to be significantly lower with a mean of 8.6 ng/mL (P < .02). Conclusion: Zonulin levels are not a guide in the diagnosis of acute pancreatitis, in determining its severity, and in the development of sepsis and organ dysfunction. The zonulin level at the time of diagnosis may be helpful in predicting complicated acute pancreatitis. Zonulin levels are not effective in demonstrating necrosis or infected necrosis. Cite this article as: Avcıoğlu U, Eruzun H. Serum zonulin levels as an early biomarker in predicting the severity and complications of acute pancreatitis. Eurasian J Med 2023;55(1):78-82.

18 March 2021 in Journal of Experimental and Clinical Medicine
Verified
Journal Article
Closed access
BBBerk Baş
Berk Baş
TATalat Ayyildiz
Talat Ayyildiz
UAUFUK AVCIOGLU
UFUK AVCIOGLU
Upper and lower gastrointestinal bleeding is a medical problem that is encountered in the clinic quite often. Endoscopic procedures still constitute the basis of the treatment in gastrointestinal bleeding. Hemoclips, argon plasma coagulation, sclerotherapy, heater probe, and hemosprays accompanied by endoscopy are used alone or in combination. In this study, we shared our experience of using the drug called Ankaferd blood stopper, which is indicated for use in many forms of bleeding, in 64 patients who applied to our clinic with upper or lower gastrointestinal bleeding between January 2019 and April 2020.

1 September 2023 in Gastroenterology Nursing
Verified
Journal Article
Closed access
OKOmer Kucukdemirci
Omer Kucukdemirci
SŞSeher Gönen Şentürk
Seher Gönen Şentürk
HEHasan Eruzun
Hasan Eruzun
MUMuge Ustaoglu
Muge Ustaoglu
UAUFUK AVCIOGLU
UFUK AVCIOGLU